Health Care

Eric Lefkofky’s Tempus Labs Provides Precision Medicine to Cancer Patients

Release Fact’s recent article, “Eric Lefkofksy’s Tempus Labs Uses Big Data Analytics to Revolutionize Cancer Medicine” by editor-in-chief, Brian Harris, describes the recent successes of the biotechnology company. Eric Lefkofksy is known as a leading entrepreneur with companies like Groupon and Echo Global. His latest venture, Tempus Labs, was created to provide precision medicine to cancer patients.

The article reveals that Tempus has had a large impact on the biotech space since its inception three years ago. It became recognized as one of the top startups in health tech by using genome sequencing and a library of data to create an interactive platform for cancer physicians. The platform allows the doctors to access data to perceive what medicine has worked historically for patients with similar diagnoses and body chemistry. This real-time data access permits the physicians to understand the patients’ individual tumor at the molecular level to give them actionable insights.

Some recent successes of Tempus Labs have been the groundbreaking technology that uses gene therapy to treat diseases previously determined as untreatable. For example, they use gene editing to target mutations that cause vision loss. They have also used machine learning technology to create an algorithm that identifies malignant and benign skin cancers. The algorithm is so advanced that it claims to match physicians’ ability to identify it.

The company is also testing technology like a smartwatch that monitors blood pressure, AI that looks for diseases in the eye like diabetic retinopathy, and glucose sensors that directly apply insulin.

Tempus was founded in 2015 after Lefkofsky experienced the diagnosis of a loved one. The company has been valued at $700 million and raised nearly $130 million in funding. They focus specifically on genome sequencing to provide real-time information to physicians so they can make decisions backed by data. The company has collaborated with a variety of top research universities and cancer centers around the nation.

Eric Lefkofksy resides in Chicago with his wife. He has become one of Chicago’s premier entrepreneurs and philanthropists. He is on the board of the Art Institute of Chicago, Lurie Children’s Hospital, and The Museum of Science and Industry. He also co-founded the Lefkofsky Family Foundation with his wife. They seek to provide initiatives in human rights, art, culture, and education that can have a high impact.

Learn More: lefkofskyfoundation.com/about-eric-lefkofsky/

Dr. David Samadi Finds High Blood Sugar Linked To Cancer

Doctors say high blood sugar levels increase the risk of developing pancreatic cancer. Increasing the glucose concentration by a mere 10 mg increases the carcinoma risk in the pancreas by 14 percent, according to a team of scientists. Pancreatic cancer may have the worst prognosis of all tumor types, says Dr. David Samadi. It goes unnoticed for a long time and is mostly discovered too late. However, researchers have found that there is a link between pancreatic carcinoma and diabetes, and this may help find biomarkers for early cancer detection.

The Pancreas

The pancreas is an organ, a little more than 15 centimeters long, located deep in the abdomen, between the stomach and the spine, and is surrounded by the liver, intestine and other organs. It produces pancreatic juices, which are fluids containing enzymes that contribute to digestion. It also produces insulin and other hormones and contributes to the control of blood glucose.

Dr. David Samadi says some risk factors related to the development of pancreatic cancer include:

• Smoking

• Long-term diabetes

• Obesity

• Some hereditary disorders

In the initial stages, a tumor in the pancreas usually is asymptomatic, which Dr. Samadi says can make it difficult to diagnose. The first obvious symptoms of pancreatic cancer are often:

• Pain in the back or at the at the stomach, which can come and go, becoming worse when lying down and after eating

• Unexplained weight loss

• Jaundice (yellowing of the skin and the whites of the eyes)

• Urine to be yellow or dark orange

Dr. Samadi adds that if the diagnosis is unfortunately in advanced stages, and the tumor spreads rapidly (metastasis), pancreatic cancer can be difficult to treat, but possible treatments include surgery, chemotherapy, and other targeted treatment.

Experts estimate that pancreatic cancer has increased by almost 60 percent over the last decade, and according to Dr. David Samadi, it is one of the most severe prognosis among tumors. In particular, about 3 cases of pancreatic cancer out of 10 are caused by tobacco, and this data, says Dr. Samadi, should encourage more of us to change our lifestyle.

Voted Top Doctor for more than 5 consecutive years, Dr. David Samadi is world renown for his expertise in Urology. He excels at diagnosing and treating the most advanced cases of urologic cancers. He specializes in minimally invasive surgery, and developed the SMART surgery technique.

Dr. Samadi serves as the Chairman of Urology at New York’s Lenox Hill Hospital, and other than treating patients of urologic diseases, he has been an advocate of leading a healthy lifestyle, as it can have a direct impact on tumors.

Learn More: www.crunchbase.com/person/dr-david-samadi